Sections

Alphabetical list:

A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9

News: November 21, 2009

Diabetes Drug Byetta Linked to Kidney Problems

November 21, 2009

The FDA has received 78 reports of kidney problems related to Byetta, a drug by Amylin Pharmaceuticals and Eli-Lilly prescribed to treat type 2 diabetes. With the new findings, the drug's label will be updated to warn doctors and patients about this possible side effect.

Byetta (exenatide) was approved in 2005. It's known as an incretin mimetic, which copies the action of incretin GLP-1, a hormone that is released in response to eating food which causes insulin to be secreted from the pancreas to lower blood glucose. The drug is injected twice a day, similar to insulin.

The drug recently was approved as a stand-alone treatment for controlling blood sugar, whereas previously it was prescribed for patients also on other diabetic therapies.

The reports of kidney failure were filed between April 2005 and October 2008. Sixty-two of the cases were for acute renal failure and 16 were cases of renal insufficiency. Most of the problems occurred in patients with pre-existing kidney disease or one or more risk factors for developing kidney problems. 91% of the patients were hospitalized, 18 required dialysis, 2 had kidney transplants, and 4 died. 80% stopped taking Byetta, and half of those patients had improvements to kidney function after discontinuing the drug.

Between 2005 and 2008, approximately 7 million prescriptions were written for Byetta. The FDA said, "Therefore, the 78 reported cases of altered renal funcion represent a small percentage of the total number of patients who have used the drug."

Some of the side effects of Byetta can contribute to kidney problems. For example, diarrhea, nausea and vomiting can lead to dehydration. Patients are encouraged to ask their physicians about their kidney function before taking Byetta and to monitor for signs and symptoms while taking the drug. Symptoms of kidney disease include changes in urine color, swelling in the feet and legs, fatigue, nausea or vomiting, and dull ache in the mid to lower back. If left untreated, kidney damage can worsen and lead to kidney failure.

Kidney malfunction may also occur as a consequence of diabetes itself, other chronic conditions, such as pancreatitis and hypertension. Concomitant use of certain medications (nonsteroidal anti-inflammatory drugs, diuretics, and antihypertensives) can also lead to kidney problems. Discontinuation of Byetta should only be considered if kidney dysfunction cannot be explained by these or other causes.

The FDA is advising physicians to avoid prescribing Byetta for patients with severe renal impairment, identified as creatinine clearance less than 30 mL per minute, or end-stage renal disease. It also recommends using caution when initiating or increasing doses from 5 micrograms to 10 micrograms in patients with moderate renal impairment. Physicians should monitor patients for the development of kidney dysfunction while on Byetta.

In 2007, Byetta was linked to a higher risk of acute pancreatitis, a potentially life-threatening inflammation of the pancreas. In October 2007 and August 2008, the FDA issued safety alerts about the reports that included cases of hemorrhagic pancreatitis and nectrotizing pancreatitis, which can be fatal. The symptoms of pancreatitis include nausea, vomiting, severe abdominal pain, a rise or fall in blood pressure, and increase heart or respiratory rates.

Adverse events for any medication should be reported to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

Denise Reynolds RD LDN



Archive issues: (50)

Archive list: 1 2 3 4 5 [6] 7 8 9 10 11 12 13 14 15 16 17

November 29, 2009 | Rituximab May Offer Hope To Severe Graves' Eye Disease Patients

There may be hope for patients with severe Graves' eye disease in the form of treatment with the drug rituximab.  This news comes from U-M Kellogg Eye Center who's oculoplastics specialist Raymond S. Douglas, M.D., Ph.D. reports on the potential of the drug in the online October issue of Ophthalmology.  Graves' eye disease is an autoimmune disease that causes inflammation and fatty deposits in the eye muscles and connective tissue surrounding ...

November 28, 2009 | New guidelines urged for H1N1 protection among healthcare employees

Infectious disease experts are calling for a moratorium on OSHA guidelines for health care employees that require the use of fit-tested N95 respirators for personal protection from H1N1 flu. Three leading infectious disease organizations, have written a letter to ...

November 27, 2009 | Air Pollution Raises Infants' Risk of Bronchiolitis

Infants who are exposed to higher levels of air pollution, including vehicle and industrial emissions and wood smoke, are at increased risk for bronchiolitis. The study is unique because it evaluated multiple sources of air pollution and their impact on infants' health.  Bronchiolitis is a ...

Archive list: 1 2 3 4 5 [6] 7 8 9 10 11 12 13 14 15 16 17

Related articles:

About mens health risks

  Mortality rates for all of the 15 leading causes of death for the total population are higher for males than females in America. Men die almost seven years earlier than women. Men are more likely to suffer from chronic illnesses, to suffer a traumatic brain injury, and to die from acquired immune deficiency ...

Section: Mens health risks

Chronic prostatitis/chronic pelvic pain syndrome - pharmacological treatment

  There is a substantial list of medications used to treat this disorder. Some of them are:  Quercetin has shown effective in a randomized, placebo-controlled trial in chronic prostatitis using 500 mg twice a day for 4 weeks Subsequent studies showed that quercetin, a mast cell inhibitor, reduces inflammation and oxidative stress in the ...

Section: Prostatitis

Treatment - medication (bladder coatings)

  Other bladder coating therapies include Cystistat (sodium hyaluronate) and Uracyst (chondroitin). They are believed to replace the deficient GAG layer on the bladder wall. Like most other intravesical bladder treatments, this treatment may require the patient to lie for 20 - 40 minutes, turning over every ten minutes, to allow the chemical to 'soak in' and give a good coating, before it is passed out with the ...

Section: Interstitial cystitis

News

December 20, 2009

Wii, Xbox 360 and Other Video Games Offer Some Benefits

Wii, Xbox 360, PlayStation, and other video games are hot on holiday gift lists, but some parents wonder whether these games offer any benefits or are detrimental to kids. The results of a new study may put some minds at ease, while others may not.  According to the findings reported in the latest ...

December 18, 2009

Should You Be Shoveling Snow?

Yes, the weather outside is frightful, and soon you will have to think about shoveling snow. But should you be the one doing the work? Who should and should not shovel snow, and how can you do it safely?  Every ...

December 17, 2009

Athletes who take NSAID's to prevent pain may be doing more harm than good

According to Stuart Warden, a researcher who studies musculoskeletal health and sports medicine, athletes who ritualistically take NSAID's to prevent post event and workout soreness and inflammation may be depriving the body of healing, in addition to risking other long term health problems. Taking anti inflammatory medications before running or other athletic events, is ...

Blogroll